Skip to main content
Free research Free research Free compound review with research home and workspace preview
Quick search ChEMBL 36
Compound Detail

CHEMBL231068

FLIBANSERIN
💊 Approved Drug
Enter ChEMBL ID:
Free Research Context This compound will appear in recent viewed items on the research home for this browser.
Research home View demo workspace
💊 Approved Drug
O=c1[nH]c2ccccc2n1CCN1CCN(c2cccc(C(F)(F)F)c2)CC1

Basic Information

ChEMBL ID CHEMBL231068
Name FLIBANSERIN
Phase Approved
Structure Type MOL
InChI Key PPRRDFIXUUSXRA-UHFFFAOYSA-N
Therapeutic ✓ Yes

Known Names

Addyi BIMT 17 BIMT 17 BS BIMT-17 BIMT-17-BS Ectris Flibanserin Flibanserina Flibanserine
2
Targets
3
Activities
2
Assay Types
0
PK Parameters
20
Publications
9
Known Names
3
Indications
1
Mechanisms

Molecular Properties

390.4
MW (Da)
3.17
ALogP
4
HBA
1
HBD
44.3
PSA (Ų)
0.74
QED
0
Ro5 Violations
4
Rot. Bonds

Drug Information

Molecule Type Small molecule
First Approval 2015
Availability Prescription
Chirality Achiral

Routes of Administration

Oral

Flags

Black Box Warning First in Class
USAN Stem -anserin
USAN Year 1997

Extended Properties

Molecular Formula C20H21F3N4O
MW 390.41
Aromatic Rings 3
Heavy Atoms 28
NP-Likeness -1.80

Mechanism of Action

Mechanism Action Type Target Direct Efficacy
Unknown - -

Indications

Sexual Dysfunctions, Psychological Sexual Dysfunctions, Psychological Prostatic Neoplasms

ATC Classification

G02CX02
flibanserin
Level 1: GENITO URINARY SYSTEM AND SEX HORMONES
Level 2: OTHER GYNECOLOGICALS

Drug Warnings

Black Box Warning
General Warning
Country: United States

Activity Summary

Ki 2 meas. best 7.93
EC50 1 meas. best 6.2

Target Activity Profile

Target Type Best pChEMBL Mean pChEMBL Best (nM) # Data
5-hydroxytryptamine receptor 1A
CHEMBL214
Ki 7.93 7.93 11.8 1
5-hydroxytryptamine receptor 1A
CHEMBL273
Ki 7.93 7.93 11.8 1
5-hydroxytryptamine receptor 1A
CHEMBL214
EC50 6.2 6.2 631.0 1

Activity Data Samples

Top measurements by pChEMBL value

Literature References

PubMed DOI Target Context # Activities
- 10.6019/CHEMBL4495565 SARS-CoV-2 4
17803293 10.1021/jm070714l Rattus norvegicus 3
17803293 10.1021/jm070714l 5-hydroxytryptamine receptor 1A 3
37468498 10.1038/s41467-023-40064-9 Thromboxane A2 receptor 2
37468498 10.1038/s41467-023-40064-9 Prostaglandin G/H synthase 1 2
37468498 10.1038/s41467-023-40064-9 Alpha-1A adrenergic receptor 2
- 10.6019/CHEMBL4808148 Histone deacetylase 6 2
- 10.6019/CHEMBL4651402 SARS-CoV-2 2
- 10.6019/CHEMBL4495564 Replicase polyprotein 1ab 2
35367707 10.1016/j.ejmech.2022.114319 5-hydroxytryptamine receptor 1A 1
37468498 10.1038/s41467-023-40064-9 Muscarinic acetylcholine receptor M1 1
37468498 10.1038/s41467-023-40064-9 Voltage-gated inwardly rectifying potassium channel KCNH2 1
37468498 10.1038/s41467-023-40064-9 Sodium-dependent dopamine transporter 1
37468498 10.1038/s41467-023-40064-9 Bile salt export pump 1
37468498 10.1038/s41467-023-40064-9 Estrogen receptor 1
37468498 10.1038/s41467-023-40064-9 Acetylcholinesterase 1
37468498 10.1038/s41467-023-40064-9 Sodium-dependent noradrenaline transporter 1
37468498 10.1038/s41467-023-40064-9 Alpha-2A adrenergic receptor 1
37468498 10.1038/s41467-023-40064-9 Mu-type opioid receptor 1
- 10.1101/2020.04.21.054387 SARS-CoV-2 1

Data from ChEMBL 36 via Core Engine